Instituto Rosenbusch S.A. is an Argentine laboratory with over 100 years of experience in animal health. The company produces and markets a complete line of vaccines and pharmaceutical products for livestock, equines, and companion animals. Additionally, it manufactures Biolarvicides for environmental control of disease-transmitting mosquitoes, including those responsible for Dengue and Malaria. With its headquarters in Argentina and subsidiaries in Brazil, Uruguay, and Paraguay, Instituto Rosenbusch S.A. is a leading player in the South American sector, exporting its products worldwide. The company's history dates back to 1917 when it was established within the Argentine Rural Society, the country's most representative entity in the agricultural sector. Over the years, it has built a reputation for high-quality products and continuous technical support to producers and veterinarians, positioning itself as a pioneer in the development and production of proprietary technology products. In the field of animal health and environmental care, Instituto Rosenbusch S.A. has become one of the foremost companies in Argentina and a leader in many market segments. Notably, it was the first company in its sector to be listed on the Buenos Aires Stock Exchange.
There is no investment information